We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Advanced Medical Solutions Group Plc | LSE:AMS | London | Ordinary Share | GB0004536594 | ORD 5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 2.50 | 1.19% | 213.00 | 213.50 | 214.50 | 215.00 | 205.00 | 205.00 | 286,001 | 16:35:05 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Plastics,resins,elastomers | 126.21M | 15.89M | 0.0732 | 29.30 | 465.92M |
From May 2019 to May 2024
TIDMAMS
RNS Number : 4632R
Advanced Medical Solutions Grp PLC
09 March 2016
09 March 2016
Advanced Medical Solutions Group plc
("AMS" or the "Group")
Notice of Preliminary Results
Winsford, UK: 9 March 2016 - Advanced Medical Solutions Group plc (AIM: AMS.L), a leading developer and manufacturer of advanced products for the global surgical and wound care markets, will announce its unaudited preliminary results for the year ended 31 December 2015 on Wednesday 16 March 2016.
A briefing for analysts will be held at 9.30am on the day of the results. Please contact Consilium Strategic Communications for further details.
- Ends -
For further information, please visit www.admedsol.com or contact:
Hot Features
Premium
Advanced Medical Solutions Group plc +44 (0) 1606 545508
Chris Meredith, Chief Executive Officer
Mary Tavener, Group Finance Director
Consilium Strategic Communications +44 (0) 20 3709 5700
AMS@consilium-comms.com
Mary-Jane Elliott / Jonathan Birt / Matthew Neal / Hendrik Thys
Investec Bank plc (NOMAD & Broker) +44 (0) 20 7597 5970
Gary Clarence / Daniel Adams / Patrick Robb
About Advanced Medical Solutions Group plc - see www.admedsol.com
AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands ActivHeal(R) , LiquiBand(R) and RESORBA(R) as well as supplying under white label.
AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in 65 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Group has approximately 470 employees. For more information please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NOREAXDPEAFKEFF
(END) Dow Jones Newswires
March 09, 2016 02:01 ET (07:01 GMT)
1 Year Advanced Medical Solutions Chart |
1 Month Advanced Medical Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
